Product Images Gabapentin

This appears to be a formula for calculating "Lt" (likely referring to something medical-related) using a patient's age and weight. It also mentions the value for creatinine for female patients. However, without more context or information, it is difficult to provide a more specific or useful description.*

This appears to be the presentation of data related to a clinical trial. It includes information on the dosing schedule, treatment groups (placebo vs Gatspntin), and mean pain scores at baseline and during multiple time points in the study. However, without additional context or information on the study design and objectives, it is difficult to provide a more detailed description of the data.*

This is a graph labeled as "Figure 3" that displays the proportion of responders, which are patients with more than 50% reduction in pain score, in controlled PHN studies. The graph compares three different treatment groups (PBO, GBP 3600, and GBP 1800/2400) across two studies (Study 1 and Study 2). The y-axis goes from 0% to 100%, and the x-axis depicts the treatment groups and studies.*

This appears to be a chart or graph related to pain scores and medication dosages. It shows two four-week periods, one with a fixed dosage and the other with a medication called Gabapentin. The pain score starts at 0 and does not increase throughout the duration of both periods. However, without further context or explanation, it is not possible to provide a more detailed description or analysis.*